Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: A multilevel study

European Journal of Clinical Pharmacology

Volumn 61, Issue 2, 2005, Pages 145-151

  Kasje, Willeke N ^a   Denig, Petra ^a   Stewart, Roy E ^a   De Graeff, Pieter A ^a,b   Haaijer Ruskamp, Flora M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FOSINOPRIL; LISINOPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL;

ADULT; AGED; ARTICLE; CARDIOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL PRACTITIONER; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PATIENTS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PROFESSIONAL PRACTICE; SEX FACTORS;

EID: 18744363646     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0897-6     Document Type: Article

References (30)

1. Kulig M, Erika S, Norbert WS (2003) Comparing methodological quality and consistency of international guidelines for the management of patients with chronic heart failure. Eur J Heart Fail 5(3):327-335
2. Walma EP, Bakx HCA, Besseling RAM, Hamstra PWJ et al (1995) Dutch College of General Practitioners Guidelines of Heart failure (NHG-standaard hartfalen). Huisarts Wet 38:471-487
3. Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F et al (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360(9346):1631-1639
4. Nilsson G, Strender LE (2002) Management of heart failure in primary health care. A retrospective study on electronic patient records in a registered population. Scand J Prim Health Care 20(3):161-165
5. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A et al (2003) The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24(5):464-474
6. Pont LG, Sturkenboom MC, Van Gilst WH, Denig P, Haaijer-Ruskamp FM (2003) Trends in prescribing for heart failure in Dutch primary care from 1996 to 2000. Pharmacoepidemiol Drug Saf 12(4):327-334
7. Khunti K, Hearnshaw H, Baker R, Grimshaw G (2002) Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail 4(6):771-777
8. Hickling JA, Nazareth I, Rogers S (2001) The barriers to effective management of heart failure in general practice. Br J Gen Pract 51(469):615-618
9. Fuat A, Hungin AP, Murphy JJ (2003) Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 326(7382):196
10. Horne R, Coombes I, Davies G, Hankins M, Vincent R (1999) Barriers to optimum management of heart failure by general practitioners. Br J Gen Pract 49(442):353-357
11. Edep ME, Shah NB, Tateo IM, Massie BM (1997) Differences between primary care physicians and cardiologists on management of congestive heart failure: relation to practice guidelines. J Am College Cardiol 30:518-526
12. Rutten FH, Grobbee DE, Hoes AW (2003) Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 5(3):337-344
13. Akosah KO, Schaper AM, Havlik P, Barnhart S, Devine S (2002) Improving care for patients with chronic heart failure in the community: the importance of a disease management program. Chest 122(3):906-912
14. Mejhert M, Holmgren J, Wandell P, Persson H, Edner M (1999) Diagnostic tests, treatment and follow-up in heart failure patients - is there a gender bias in the coherence to guidelines? Eur J Heart Fail 1(4):407-410
15. Johansson S, Wallander MA, Ruigomez A, Garcia R (2002) Treatment patterns among newly diagnosed heart failure patients in general practice. Eur J Clin Pharmacol 57(11):813-817
16. Hood S, Taylor S, Roeves A, Crook AM, Tlusty P, Cohen J et al (2000) Are there age and sex differences in the investigation and treatment of heart failure? A population-based study. Br J Gen Pract 50(456):559-563
17. Ahmed A, Allman RM, Kiefe CI, Person SD, Shaneyfelt TM, Sims RV et al (2003) Association of consultation between generalists and cardiologists with quality and outcomes of heart failure care. Am Heart J 145(6):1086-1093
18. Schaars CF, Denig P, Kasje WN, Stewart RE, Wolffenbuttel BHR, Haaijer-Ruskamp FM (2004) Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care. Diabetes Care 27(1):123-128
19. Luzier AB, Forrest A, Adelman M, Hawari FI, Schentag JJ, Izzo JL Jr (1998) Impact of angiotensin-converting enzyme inhibitor under dosing on rehospitalization rates in congestive heart failure. Am J Cardiol 82(4):465-469
20. Kasje WN, Denig P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM. Perceived barriers for treatment of chronic heart failure in general practice. Are they affecting performance? BMC Fam Pract submitted.
21. Snijders T, Bosker R (2002) Multilevel analysis. An introduction to basic and advanced multilevel modeling, 2nd edn. SAGE, London
22. Khunti K, Baker R, Grimshaw G (2000) Diagnosis of patients with chronic heart failure in primary care: usefulness of history, examination, and investigations. Br J Gen Pract 50(450):50-54
23. McColl A, Roderick P, Smith H, Wilkinson E, Moore M, Exworthy M et al (2000) Clinical governance in primary care group: the feasibility of deriving evidence-based performance indicators. Qual Health Care 9:90-97
24. NHS Quality indicators (2004) Available at: http://www.nhs-confed.org/ docs/annex_a_quality_indicators.doc
25. Grady KL, Dracup K, Kennedy G, Moser DK, Piano M, Stevenson LW et al (2000) Team management of patients with heart failure - a statement for healthcare professionals from the Cardiovascular Nursing Council of the American Heart Association. Circulation 102(19):2443-2456
26. Sparrow N, Adlam D, Cowley A, Hampton JR (2003) The diagnosis of heart failure in general practice: implications for the UK National Service Framework. Eur J Heart Fail 5:349-354
27. Gambassi G, Lapane KL, Sgadari A, Carbonin P, Gatsonis C, Lipsitz LA et al (2000) Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. Arch Intern Med 160(1):53-60
28. Shah MR, Granger CB, Bart BA, McMurray JJV, Petrie MC, Michelson EL et al (2000) Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry. Am J Med 109(6):489-492
29. Manyemba J, Mangoni A, Pettingale K, Jackson S (2003) Determinants of failure to prescribe target doses of angiotensin-converting enzyme inhibitors for heart failure. Eur J Heart Fail 5(5):693-696
30. Pont LG, van Gilst WH, Lok DJ, Kragten HJ, Haaijer-Ruskamp FM (2003) Dutch working group on heart failure. The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice. Eur J Heart Fail 5(2):187-193